US 12,102,630 B2
	Crystalline forms and processes of lenvatinib besylate
Luis Nogueiras Nieto, Sant Boi de Llobregat (ES); Lisardo Alvarez Fernandez, Sant Boi de Llobregat (ES); Raymond Westheim, Nijmegen (NL); and Katerina Jelinkova, Blansko (CZ)
Assigned to Synthon B.V., Nijmegen (NL)
Appl. No. 17/282,505
Filed by Synthon B.V., Nijmegen (NL)
PCT Filed Oct. 1, 2019, PCT No. PCT/EP2019/076622 § 371(c)(1), (2) Date Apr. 2, 2021, PCT Pub. No. WO2020/070144, PCT Pub. Date Apr. 9, 2020.
Claims priority of application No. 18198662 (EP), filed on Oct. 4, 2018; and application No. 19172395 (EP), filed on May 2, 2019.
Prior Publication US 2022/0062263 A1, Mar. 3, 2022
Int. Cl. A61K 31/47 (2006.01); A61K 9/48 (2006.01); C07D 215/48 (2006.01)

CPC A61K 31/47 (2013.01) [A61K 9/485 (2013.01); A61K 9/4858 (2013.01); A61K 9/4866 (2013.01); C07D 215/48 (2013.01); C07B 2200/13 (2013.01)]

26 Claims

1. A lenvatinib besylate salt.